http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17600437

Outgoing Links

Predicate Object
contentType Journal Article
issn 1758-5996
issueIdentifier 1
pageRange 61-
publicationName Diabetology & Metabolic Syndrome
startingPage 61
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_41df63f508b490bf190f16bdf6cfb8de
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1cdadfa5eda88a1827252e4d4f0c3ed6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_19625f029bb5f4d5cb0d419ac0802fb9
bibliographicCitation McGill JB, Johnson M, Hurst S, Cade WT, Yarasheski KE, Ostlund RE, Schechtman KB, Razani B, Kastan MB, McClain DA, de las Fuentes L, Davila-Roman VG, Ory DS, Wickline SA, Semenkovich CF. Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness. Diabetology & Metabolic Syndrome. 2019 Jul 29;11(1):61. doi: 10.1186/s13098-019-0456-4.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05524968e26e30301a4f1b6e2a3e263b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6228-6521
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e76669f1d74636600456717b92d5ca40
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0de0a43af883963598452d01f4526765
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4f133b08544d3264c70975951801ff5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d2f094c32401643dbda9c30f7c69d96
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed747fa7b497c7b2345579ee1c919de0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0be32ca88da790fdef9b72d79bc873e5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ed22543ca03c859da3f80e4bc18fbb7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c324e6351b786d532a4fad6b984c75a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4689-325X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_caf5fe5b18c3eeec48140177f5183b39
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04a1d9854c676f839a6cec9f049b0f5f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1252b9819a94010035c2c36f9201a96
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_367f3473969ce57d77506d5d890e0eb3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_190f3f27ce8fbcb1903e35bb236afd8a
date 2019-07-29^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC6664523
https://pubmed.ncbi.nlm.nih.gov/31384309
https://doi.org/10.1186/s13098-019-0456-4
isPartOf https://portal.issn.org/resource/ISSN/1758-5996
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35537
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10708
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d8f94598af1b5110c615f34697fe502
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07edfd5399a4297179b0eb6e7ec0142a
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10898

Showing number of triples: 1 to 53 of 53.